Harel Insurance Investments & Financial Services Ltd. Organon & Co. Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.8 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$28.67 - $37.13 $1,806 - $2,339	-63 Closed	0 $0
Q3 2021 Oct 25, 2021	SELL	$28.63 - $35.64 $23,247 - $28,939	-812 Reduced 92.8%	63 $2,000
Q2 2021 Jul 26, 2021	BUY	$28.45 - $38.0 $24,893 - $33,250	875 New	875 $86,000

Others Institutions Holding OGN

# of Institutions

794

Shares Held

193M

Call Options Held

1.71M

Put Options Held

865K

Black Rock Inc. New York, NY

32.6M
Shares

$527 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

30.2M
Shares

$488 Million
0.01% of portfolio
Massachusetts Financial Services CO Boston, MA

9.76M
Shares

$158 Million
0.06% of portfolio
State Street Corp Boston, MA

8.98M
Shares

$145 Million
0.01% of portfolio
Lsv Asset Management Chicago, IL

7.49M
Shares

$121 Million
0.31% of portfolio

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.11B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account